Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Search results

Blog | August 08, 2019

5G Developments: From Rollout to Regulation

Blog | July 03, 2019

EDTX & WDTX Monthly Wrap-Up — June 2019

Blog | June 11, 2019

Navigating Uncertainty: Addressing Purely Functional Claim Limitations in a Post-Williamson World with Ongoing PTAB Climate Change

Blog | May 28, 2019

EDTX & NDTX Monthly Wrap-Up — April 2019

Blog | May 03, 2019

Venue in Hatch-Waxman Actions is Governed by 28 U.S.C. § 1400(b) Not § 1391(b)

Blog | May 03, 2019

Massachusetts Patent Litigation Wrap Up — March 2019

Blog | April 24, 2019

EDTX & NDTX Monthly Wrap-Up — March 2019

Blog | April 12, 2019

Who Can Be A Defendant In Biosimilar Patent Litigation?

Blog | March 19, 2019

Massachusetts Patent Litigation Wrap Up — January 2019

Q&A | March 18, 2019

Q&A with Kurt Glitzenstein for Corporate Counsel Business Journal

Blog | March 14, 2019

Discovery Battles in AbbVie v. Boehringer Ingelheim

Blog | March 11, 2019

EDTX & NDTX Monthly Wrap-Up — February 2019